Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

NCT02227368 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease (PAD)

Interventions

DRUG: Ticagrelor
DRUG: Comparator

Sponsor

AstraZeneca

Collaborators

[object Object]